• Issue

    American Journal of Hematology: Volume 98, Issue 5

    701-832, E95-E129
    May 2023
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 701-702
  • First Published: 10 April 2023

RESEARCH ARTICLES

Open Access

Open-label, Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies

John Glaspy,  Nashat Y. Gabrail,  Patricia Locantore-Ford,  Tyson Lee,  Katharina Modelska,  Vivek Samal,  David H. Henry, 
  • Pages: 703-711
  • First Published: 29 January 2023
Open-label, Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies

Open-label, Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies.

Free Access

Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS

Curtis Marcoux,  David Marin,  Jeremy Ramdial,  Gheath AlAtrash,  Amin M. Alousi,  Betul Oran,  Partow Kebriaei,  Uday R. Popat,  Katayoun Rezvani,  Richard E. Champlin,  Elizabeth J. Shpall,  Rohtesh S. Mehta, 
  • Pages: 712-719
  • First Published: 02 February 2023
Open Access

Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choice

Vaishali Sanchorawala,  Ashutosh D. Wechalekar,  Kihyun Kim,  Stefan O. Schönland,  Heather J. Landau,  Fiona Kwok,  Kenshi Suzuki,  Angela Dispenzieri,  Giampaolo Merlini,  Raymond L. Comenzo,  Dasha Cherepanov,  Vanessa C. Hayden,  Arun Kumar,  Richard Labotka,  Douglas V. Faller,  Efstathios Kastritis, 
  • Pages: 720-729
  • First Published: 28 January 2023
Free Access

Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study group

Eirini Katodritou,  Efstathios Kastritis,  Dimitra Dalampira,  Sosana Delimpasi,  Emmanouil Spanoudakis,  Vasiliki Labropoulou,  Ioannis Ntanasis-Stathopoulos,  Annita-Ioanna Gkioka,  Nikos Giannakoulas,  Nikolaos Kanellias,  Theodosia Papadopoulou,  Aggeliki Sevastoudi,  Eyrydiki Michalis,  Maria Papathanasiou,  Maria Kotsopoulou,  Anastasia Sioni,  Theodora Triantafyllou,  Aikaterini Daiou,  Mavra Papadatou,  Marie-Christine Kyrtsonis,  Anastasia Pouli,  Ioannis Kostopoulos,  Evgenia Verrou,  Meletios-Athanasios Dimopoulos,  Evangelos Terpos, 
  • Pages: 730-738
  • First Published: 04 March 2023
Free Access

DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study

Scott F. Huntington,  Stephen J. Schuster,  Wei Ding,  Amber B. Koehler,  Danielle M. Brander,  Allison C. Rosenthal,  Jose F. Leis,  Han W. Tun,  Muhamad Alhaj Moustafa,  Madiha Iqbal,  Wei He,  Albert S. Kearney,  Timothy P. McKinlay,  Min Gui,  Anthony R. Mato, 
  • Pages: 739-749
  • First Published: 21 February 2023
Free Access

Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing

Suzanne O. Arulogun,  Duncan Brian,  Harshita Goradia,  Aaron Cooney,  Tobias Menne,  RayMun Koo,  Aideen T. O'Neill,  Josephine M. I. Vos,  Guy Pratt,  Deborah Turner,  Kirsty Marshall,  Kate Manos,  Claire Anderson,  Maria Gavriatopoulou,  Charalampia Kyriakou,  Marie J. Kersten,  Monique C. Minnema,  Eirini Koutoumanou,  Dima El-Sharkawi,  Kim Linton,  Dipti Talaulikar,  Helen McCarthy,  Mark Bishton,  George Follows,  Ashutosh Wechalekar,  Shirley P. D'Sa, 
  • Pages: 750-759
  • First Published: 03 March 2023
Free Access

Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia

Min-Yen Lo,  Xavier Cheng-Hong Tsai,  Chien-Chin Lin,  Feng-Ming Tien,  Yuan-Yeh Kuo,  Wan-Hsuan Lee,  Yen-Ling Peng,  Ming-Chih Liu,  Mei-Hsuan Tseng,  Cheng-An Hsu,  Jui-Che Chen,  Liang-In Lin,  Hsun-I Sun,  Yi-Kuang Chuang,  Bor-Sheng Ko,  Jih-Luh Tang,  Ming Yao,  Wen-Chien Chou,  Hsin-An Hou,  Hwei-Fang Tien, 
  • Pages: 760-769
  • First Published: 02 March 2023
Open Access

Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms

Daniel Ivanov,  Jelena D. Milosevic Feenstra,  Irina Sadovnik,  Harald Herrmann,  Barbara Peter,  Michael Willmann,  Georg Greiner,  Katharina Slavnitsch,  Emir Hadzijusufovic,  Thomas Rülicke,  Maik Dahlhoff,  Gregor Hoermann,  Sigrid Machherndl-Spandl,  Gregor Eisenwort,  Michael Fillitz,  Thamer Sliwa,  Maria-Theresa Krauth,  Peter Bettelheim,  Wolfgang R. Sperr,  Elisabeth Koller,  Michael Pfeilstöcker,  Heinz Gisslinger,  Felix Keil,  Robert Kralovics,  Peter Valent, 
  • Pages: 770-783
  • First Published: 22 February 2023
Free Access

Evaluation of the clinical significance of global mRNA alternative splicing in patients with acute myeloid leukemia

Yi-Tsung Yang,  Chi-Yuan Yao,  Po-Ju Chiu,  Chein-Jun Kao,  Hsin-An Hou,  Chien-Chin Lin,  Wen-Chien Chou,  Hwei-Fang Tien, 
  • Pages: 784-793
  • First Published: 01 March 2023

CRITICAL REVIEW

Open Access

Myeloproliferative neoplasms and splanchnic vein thrombosis: Contemporary diagnostic and therapeutic strategies

Jean-Jacques Kiladjian MD, PhD,  Bruno Cassinat PharmD, PhD, 
  • Pages: 794-800
  • First Published: 04 March 2023
Myeloproliferative neoplasms and splanchnic vein thrombosis: Contemporary diagnostic and therapeutic strategies

Diagnostic work-up for myeloproliferative neoplasms in patients with splanchnic vein thrombosis.

ANNUAL CLINICAL UPDATES IN HEMATOLOGICAL MALIGNANCIES

Free Access

Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management

Ayalew Tefferi, 
  • Pages: 801-821
  • First Published: 21 January 2023

CLINICAL PEARLS IN BLOOD DISEASES

MORPHOLOGY UPDATE

Free Access

Diagnosis of histiocytic sarcoma by bone marrow aspiration

Jean-Baptiste Rieu,  Alban Canali,  François Vergez,  Barbara J. Bain, 
  • Pages: 822-823
  • First Published: 20 December 2022

CLINICAL PROBLEM SOLVING

Free Access

A young woman with persistent sore throat, Epstein–Barr virus, lymphadenopathy, and aberrant CD4 + CD7- T-cells

Mariam Goubran,  Eric McGinnis,  Ryan J. Stubbins,  Hamish Nicolson,  Persia Pourshahnazari,  Sara Belga,  Hayley Merkeley,  Thomas J. Nevill,  Luke Y. C. Chen, 
  • Pages: 824-829
  • First Published: 06 January 2023
A young woman with persistent sore throat, Epstein–Barr virus, lymphadenopathy, and aberrant CD4 + CD7- T-cells

A young woman with persistent EBV viremia and lymphocytosis had an abnormal CD4- T cell population with aberrant loss of CD7. She had a diagnosis of chronic active EBV (CAEBV), a lymphoproliferative disorder for which she ultimately required allogeneic hematopoietic stem cell transplantation.

IMAGES IN HEMATOLOGY

Free Access

Occult recurrent breast cancer masquerading as thrombotic thrombocytopenic purpura

Beatriz Wills-Sanin,  James N. George,  Leonardo Boiocchi,  Gerald A. Soff,  Jodi V. Mones, 
  • Pages: 830-832
  • First Published: 12 October 2022
Occult recurrent breast cancer masquerading as thrombotic thrombocytopenic purpura

GATA3 immunohistochemistry stain of the bone marrow biopsy required to diagnose recurrent metastatic breast cancer.

CORRESPONDENCE

Free Access

The association between renal function decline and disease severity in sickle cell disease

Aafke E. Gaartman,  Charlotte F. J. van Tuijn,  Erfan Nur,  Liffert Vogt,  Bart J. Biemond, 
  • Pages: E95-E97
  • First Published: 23 January 2023
Free Access

Factor H autoantibodies contribute to complement dysregulation in multisystem inflammatory syndrome in children (MIS-C)

Patricia E. Zerra,  Jennifer Stowell,  Hans Verkerke,  James McCoy,  Jayre Jones,  Sara Graciaa,  Austin Lu,  Laila Hussaini,  Evan J. Anderson,  Christina A. Rostad,  Sean R. Stowell,  Satheesh Chonat, 
  • Pages: E98-E101
  • First Published: 30 January 2023
Free Access

Germline and somatic RUNX1 variants in a pediatric bone marrow failure cohort

Ayako Yamamori,  Motoharu Hamada,  Hideki Muramatsu,  Manabu Wakamatsu,  Asahito Hama,  Atsushi Narita,  Yusuke Tsumura,  Taro Yoshida,  Takehiko Doi,  Kazuki Terada,  Takeshi Higa,  Nobuyuki Yamamoto,  Hiroki Miura,  Mitsutaka Shiota,  Kenichiro Watanabe,  Nao Yoshida,  Ryo Maemura,  Masayuki Imaya,  Shunsuke Miwata,  Kotaro Narita,  Shinsuke Kataoka,  Rieko Taniguchi,  Kyogo Suzuki,  Nozomu Kawashima,  Nobuhiro Nishio,  Hideto Iwafuchi,  Masafumi Ito,  Seiji Kojima,  Yusuke Okuno,  Yoshiyuki Takahashi, 
  • Pages: E102-E105
  • First Published: 05 February 2023
Free Access

Ruxolitinib combined with dexamethasone in adult patients with newly diagnosed Hemophagocytic lymphohistiocytosis: A single-center pilot trial

De Zhou,  Xianbo Huang,  Mixue Xie,  Lixia Zhu,  Xin Huang,  Xueying Li,  Xiudi Yang,  Li Li,  Jingjing Zhu,  Xiaolong Zheng,  Jianai Sun,  Shuqi Zhao,  Wenjuan Yu,  Wanzhuo Xie,  Hongyan Tong,  Jie Jin,  Honghu Zhu,  Xiujin Ye, 
  • Pages: E106-E109
  • First Published: 15 February 2023
Free Access

Relevance of Howell-Jolly body counts for measuring spleen function in sickle cell disease

Charlotte Pourdieu,  Sara El Hoss,  Enora Le Roux,  Justine Pages,  Bérengère Koehl,  Florence Missud,  Laurent Holvoet,  Ghislaine Ithier,  Malika Benkerrou,  Zinedine Haouari,  Lydie Da Costa,  Wassim El Nemer,  Sandrine Laurance,  Yves Colin Aronovicz,  Caroline Le Van Kim,  Odile Fenneteau,  Elodie Lainey,  Valentine Brousse, 
  • Pages: E110-E112
  • First Published: 16 February 2023
Free Access

Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemia

Benjamin J. Lee,  Shawn P. Griffin,  Jean Doh,  Piyanuch Kongtim,  Alexandre Chan,  Susan O'Brien,  Deepa Jeyakumar,  Stefan O. Ciurea, 
  • Pages: E113-E115
  • First Published: 16 February 2023
Free Access

Impact of sex on outcomes in patients with hairy cell leukemia. An HCL patient data registry analysis

Narendranath Epperla,  Qiuhong Zhao,  Mirela Anghelina,  Jasmine Neal,  James S. Blachly,  Kerry A. Rogers,  Gerard Lozanski,  Christopher C. Oakes,  Seema A. Bhat,  Clive S. Zent,  Versha Banerji,  Michael Grever,  Leslie A. Andritsos, 
  • Pages: E116-E118
  • First Published: 20 February 2023
Free Access

The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms

Panagiotis T. Diamantopoulos,  Elena Solomou,  Argiris Symeonidis,  Vasiliki Pappa,  Ioannis Kotsianidis,  Athanasios Galanopoulos,  Charalampos Pontikoglou,  Achilles Anagnostopoulos,  George Vassilopoulos,  Panagiotis Zikos,  Eleftheria Hatzimichael,  Maria Papaioannou,  Aekaterini Megalakaki,  Theodoros Vassilakopoulos,  Maria Dimou,  Dimitrios Tsokanas,  Menelaos-Konstantinos Papoutselis,  Sotirios Papageorgiou,  Alexandra Kourakli,  Helen Papadaki,  Panayiotis Panayiotidis,  Nora-Athina Viniou, 
  • Pages: E119-E122
  • First Published: 20 February 2023
Free Access

XBB.1.5 neutralizing antibodies upon bivalent COVID-19 vaccination are similar to XBB but lower than BQ.1.1

Santhi Devasundaram,  Evangelos Terpos,  Margherita Rosati,  Ioannis Ntanasis-Stathopoulos,  Jenifer Bear,  Robert Burns,  Stamatia Skourti,  Panagiotis Malandrakis,  Ioannis P. Trougakos,  Meletios-Athanasios Dimopoulos,  George N. Pavlakis,  Barbara K. Felber, 
  • Pages: E123-E126
  • First Published: 21 February 2023
Open Access

Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first-line JAK-inhibitor

James T. England,  Eshetu G. Atenafu,  James A. Kennedy,  Burhan Goraya,  Verna Cheung,  Taylor Nye,  Karine Gauthier,  Marta B. Davidson,  Aniket Bankar,  Hassan Sibai,  Dawn Maze,  Auro Viswabandya,  Vikas Gupta, 
  • Pages: E127-E129
  • First Published: 22 February 2023